Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic prophylaxis regimens in adult liver transplant recipients
IRCT20120731010453N2Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Nov 2018
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in bacterial disease comparing Ampicillin-sulbactam + ceftizoxime with Ampicillin-sulbactam + gentamicin (2 arms). Primary endpoints: Length of hospital stay, Mortality rate and 3 more. Started Nov 2018; status: completed.
02
Drugs
ampicillin + sulbactamceftizoximegentamicin
03
Conditions
bacterial disease
Beyond the preview
Go deeper on IRCT20120731010453N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120731010453N2.